RI
XGN icon

RTW Investments’s Exagen XGN Stock Holding History

RTW Investments’s Portfolio XGN Stock Details XGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$907K Sell
195,000
-200,231
-51% -$754K 0.01% 83
2026
Q1 		$1.19M Sell
395,231
-395,231
-50% -$1.53M 0.01% 87
2025
Q4 		$4.81M Sell
790,462
-906,404
-53% -$8.25M 0.05% 80
2025
Q3 		$18.6M Hold
1,696,866
– – 0.23% 57
2025
Q2 		$11.8M Buy
1,696,866
+185,000
+12% +$1.12M 0.17% 58
2025
Q1 		$5.43M Hold
1,511,866
– – 0.08% 59
2024
Q4 		$6.2M Hold
1,511,866
– – 0.09% 58
2024
Q3 		$4.67M Hold
1,511,866
– – 0.07% 60
2024
Q2 		$2.75M Buy
1,511,866
+7,264
+0.5% +$12.3K 0.04% 61
2024
Q1 		$2.39M Hold
1,504,602
– – 0.04% 65
2023
Q4 		$2.99M Buy
1,504,602
+12,170
+0.8% +$21K 0.05% 59
2023
Q3 		$3.61M Hold
1,492,432
– – 0.08% 58
2023
Q2 		$4.33M Buy
1,492,432
+101,248
+7% +$288K 0.08% 57
2023
Q1 		$3.38M Buy
1,391,184
+26,848
+2% +$69.4K 0.07% 53
2022
Q4 		$3.27M Buy
1,364,336
+315,674
+30% +$810K 0.07% 67
2022
Q3 		$2.84M Buy
1,048,662
+23,660
+2% +$132K 0.07% 77
2022
Q2 		$5.88M Buy
1,025,002
+34,859
+4% +$203K 0.15% 75
2022
Q1 		$7.95M Buy
990,143
+168,729
+21% +$1.45M 0.16% 69
2021
Q4 		$9.55M Hold
821,414
– – 0.14% 83
2021
Q3 		$11.2M Hold
821,414
– – 0.17% 75
2021
Q2 		$12.3M Sell
821,414
-804,951
-49% -$12.3M 0.19% 66
2021
Q1 		$28.5M Buy
1,626,365
+376,234
+30% +$6.7M 0.44% 54
2020
Q4 		$16.5M Hold
1,250,131
– – 0.28% 60
2020
Q3 		$13.6M Sell
1,250,131
-5,000
-0.4% -$64.4K 0.33% 58
2020
Q2 		$15.6M Sell
1,255,131
-509
-0% -$6.89K 0.44% 46
2020
Q1 		$20M Buy
1,255,640
+536,694
+75% +$10.7M 0.86% 35
2019
Q4 		$18.3M Buy
718,946
+207,313
+41% +$3.69M 0.69% 33
2019
Q3 		$7.92M Buy
+511,633
New +$8.26M 0.47% 42

Other funds holding XGN

WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $130M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FCM
FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $227M AUM 64.76% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

RTW Investments's XGN Position: Q2 2026 in Review

RTW Investments reduced its Exagen (XGN) stake by 51% in Q2 2026, selling an estimated $754K and leaving 195,000 shares worth $907K. The position accounts for 0.01% of the portfolio, ranked #83.

RTW Investments first reported a position in XGN in Q3 2019 and has held it in 28 quarters since. The position peaked at $28.5M in Q1 2021. 57 funds tracked by Wall St. Rank hold XGN as of Q2 2026.

  • RTW Investments held 195,000 shares of Exagen worth $907K as of Q2 2026.
  • RTW Investments sold 200,231 Exagen shares in Q2 2026, an estimated $754K.
  • Exagen made up 0.01% of RTW Investments's portfolio in Q2 2026, its #83 holding.
  • RTW Investments first reported a position in Exagen in Q3 2019 and has held it in 28 quarters since.
  • RTW Investments's Exagen position peaked at $28.5M in Q1 2021.
  • 57 funds tracked by Wall St. Rank held Exagen as of Q2 2026.

Based on RTW Investments's 13F filing for Q2 2026, filed 14 Aug 2026.